Action of optimum cytokine for the recovery of X-irradiated human hematopoietic stem and progenitor cells

最佳细胞因子对 X 射线照射的人类造血干细胞和祖细胞恢复的作用

基本信息

  • 批准号:
    12672115
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

We obtained the results from the project titled "Action of optimum cytokine for the recovery of X-irradiated human hematopoietic stem and progenitor cells" for the period from 2000 to 2001. The following points were clarified.(1) Human placental/umbilical cord blood (CB) CD34^+ CFU-Meg (megakaryocyte colony-forming units) is more radiosensitive than the other myeloid hematopoietic progenitor cells, including erythroid burst-forming units, granulocyte-macrophage colony-forming units and granulocyte-erythroid-macrophage-megakaryocyte colony-forming units.(2) The proportion of large megakaryocyte colonies, immature CFU-Meg, was 60 - 78% of the total number of colonies in all combinations we tested. The immature CFU-Meg is more radiosensitive than the mature CFU-Meg. In contrast, the total CFU-Meg from normal human peripheral blood (PB) is more radiosensitive than those in CB, despite the predominance of mature CFU-Meg in PB.(3) The combination of cytokines, including thrombopoietin (TPO), interleukin-3 (IL-3) and stem cell factor (SCF), is effective for the radiation survival of CB CD34^+ CFU-Meg in all cytokine combinations we tested. In the case of PB CD34^+ CFU-Meg, the combination of TPO plus IL-3 is most effective for the radiation survival of CFU-Meg than the others.(4) The result indicated that part of the synergistic effect of TPO plus SCF can be explained by the activation of mitogen-activated protein kinase and extracellular-signal-regulated protein kinase and the suppression of caspase cascade.(5) The synergistic effect of TPO and IL-3 for the radiation survival of PB CD34^+ CFU-Meg is involved the JAK/STAT (janus kinase/signal transducer and activator of transcription), however, no involvement of phosphatidylinositol-3-kinase-related signals transduction is shown.
我们从2000年至2001年期间获得了题为“最佳细胞因子对X射线照射的人造血干细胞和祖细胞恢复的作用”的项目的结果。澄清了以下几点。(1)人胎盘/脐带血(CB)CD 34 ^+ CFU-Meg(巨核细胞集落形成单位)比其他骨髓造血祖细胞(包括红系爆发集落形成单位、粒细胞-巨噬细胞集落形成单位和粒细胞-红系-巨噬细胞-巨核细胞集落形成单位)更敏感。(2)在我们测试的所有组合中,大巨核细胞集落(未成熟CFU-Meg)的比例为集落总数的60 - 78%。未成熟的CFU-Meg比成熟的CFU-Meg更敏感。相反,尽管正常人外周血(PB)中成熟CFU-Meg占优势,但其总CFU-Meg比CB中的CFU-Meg更放射敏感。(3)在我们测试的所有细胞因子组合中,包括血小板生成素(TPO)、白细胞介素-3(IL-3)和干细胞因子(SCF)的细胞因子组合对CB CD 34 ^+ CFU-Meg的辐射存活有效。在PB CD 34 ^+ CFU-Meg的情况下,TPO + IL-3的组合对CFU-Meg的辐射存活最有效。(4)结果表明,TPO与SCF协同作用的部分机制可能是通过激活丝裂原活化蛋白激酶(MAPK)和细胞外信号调节蛋白激酶(ERK),抑制caspase级联反应而实现的。(5)TPO和IL-3对PB CD 34 ^+ CFU-Meg辐射存活的协同作用涉及JAK/STAT(janus kinase/signal transducer and activator of transcription),而没有显示出涉及磷脂酰肌醇-3-激酶相关的信号转导。

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ikuo Kashiwakura, et al.: "Effect of the Combination of Thrombopoietin with Cytokines for Survival of X-irradiated CD34^+ Megakaryocytic Progenitor Cells from Normal Human Peripheral Blood"Radiat.Res.. (In press). (2002)
Ikuo Kashiwakura 等人:“血小板生成素与细胞因子的组合对来自正常人外周血的 X 照射 CD34^ 巨核细胞祖细胞存活的影响”Radiat.Res..(正在印刷中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ikuo Kashiwakura, et al.: "Proliferation-Promoting and Radioprotevtive Activities of Amifostine on the Clonal Growth of Megakaryocytic Progenitor Cells"Jounal of Radiation Research. 42・4. 539 (2001)
Ikuo Kashiwakura 等人:“Amifostine 对巨核细胞祖细胞克隆生长的增殖促进和放射保护活性”,放射研究杂志 42・4(2001 年)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ikuo Kashiwakura et al.: "Radiation Sensitivity of CD34^+ Megakaryocyte Colony-Forming Cells from Human Umbilical Cord Blood and Peripheral Blood and the Effects of Cytokines on Megakaryopoiesis In Vitro"Journal of Radiation Research. 41. 431 (2000)
Ikuo Kashiwakura 等人:“来自人脐带血和外周血的 CD34^ 巨核细胞集落形成细胞的辐射敏感性以及细胞因子对体外巨核细胞生成的影响”辐射研究杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ikuo Kashiwakura, et al.: "Radioprotective Synergistic Action of Cytokine on the Clonal Growth of X-irradiated Human Megakaryocytic Progenitor Cells"Blood. 98・16. 117b (2001)
Ikuo Kashiwakura 等人:“细胞因子对 X 射线照射的人类巨核细胞祖细胞克隆生长的放射保护协同作用”血液 98・16。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ikuo Kashiwakura, et al.: "Effects of Amifostine on the Proliferation and Differentiation of Megakaryocytic Progenitor Cells"European Journal of Pharmacology. 437・1-2. 19-25 (2002)
Ikuo Kashiwakura 等人:“Amifostine 对巨核细胞祖细胞增殖和分化的影响”欧洲药理学杂志 437·1-2(2002 年)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KASHIWAKURA Ikuo其他文献

KASHIWAKURA Ikuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KASHIWAKURA Ikuo', 18)}}的其他基金

Protective effects of a combination of multiple pharmaceutical drugs on the survival of mice exposed to lethal ionizing radiation
多种药物组合对暴露于致命电离辐射的小鼠存活的保护作用
  • 批准号:
    24659553
  • 财政年份:
    2012
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The development of multifunctional drug for magnetic resonance imaging diagnosis that uses metallic complex liquid crystal compound
金属络合物液晶化合物用于磁共振成像诊断的多功能药物的开发
  • 批准号:
    22659216
  • 财政年份:
    2010
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The identification of factor (s) which regulate individual radiosensitivity of human hematopoietic stem/progenitor cells and its application
人造血干/祖细胞个体放射敏感性调节因子的鉴定及其应用
  • 批准号:
    21390336
  • 财政年份:
    2009
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Placental/Umbilical cord blood-derived mesenchymal stem cell-likestroma cells support the hematopoietic recovery of X-irradiated human CD34+ cells
胎盘/脐带血来源的间充质干细胞样基质细胞支持 X 射线照射的人 CD34 细胞的造血恢复
  • 批准号:
    18390327
  • 财政年份:
    2006
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The study of therapy for radiation-induced thrombocytopenia by using ex vivo expanded-megakaryocyte prepared from auto hematopoietic stem cell.
自体造血干细胞体外扩增巨核细胞治疗放射引起的血小板减少症的研究。
  • 批准号:
    15591253
  • 财政年份:
    2003
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The pathophysiology and therapeutic approaches of graft-versus-host disease following allogeneic hematopoietic stem cell transplantation with a focus on the role of oral microbiota.
异基因造血干细胞移植后移植物抗宿主病的病理生理学和治疗方法,重点关注口腔微生物群的作用。
  • 批准号:
    23K15301
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Psychological and social support for patients and their family members after hematopoietic stem cell transplantation who visit multiple outpatient clinics
为造血干细胞移植后到多个门诊就诊的患者及其家属提供心理和社会支持
  • 批准号:
    23K16481
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Regulation and function of aged hematopoietic stem cell (HSC) niche
衰老造血干细胞(HSC)生态位的调节和功能
  • 批准号:
    10723396
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Elucidating the role of DCAF7 on hematopoietic stem cell maintenance
阐明 DCAF7 对造血干细胞维持的作用
  • 批准号:
    10785443
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Investigating hematopoietic stem cell dysfunction during sickle cell disease
研究镰状细胞病期间的造血干细胞功能障碍
  • 批准号:
    10681829
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
The physiological and evolutionary significance of the limited site and timing of hematopoietic stem cell development
造血干细胞发育的有限位点和时间的生理和进化意义
  • 批准号:
    23H02941
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Reprogramming Gene Regulatory Networks to a Hematopoietic Stem Cell State
将基因调控网络重编程为造血干细胞状态
  • 批准号:
    10716641
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
The Role of Hsf1 in Hematopoietic Stem Cell Aging
Hsf1在造血干细胞衰老中的作用
  • 批准号:
    10749675
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Decoupling Hydrogel Stiffness and Diffusivity for Hematopoietic Stem Cell Culture and Differentiation
用于造血干细胞培养和分化的水凝胶刚度和扩散率的解耦
  • 批准号:
    10647478
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了